Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism
Crossref DOI link: https://doi.org/10.1007/s11239-016-1409-5
Published Online: 2016-08-12
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McDonnell, Brendan P.
Glennon, Kate
McTiernan, Aoife
O’Connor, Hugh D.
Kirkham, Colin
Kevane, Barry
Donnelly, Jennifer C.
Ni Áinle, Fionnuala
License valid from 2016-08-12